How many insider disclosures are linked to ADURO BIOTECH, INC.?

Available records link 22 public disclosures to ADURO BIOTECH, INC., sourced from SEC (Form 4).

Who is the top reporting insider at ADURO BIOTECH, INC.?

The top reporting insider at ADURO BIOTECH, INC. is ISAACS STEPHEN T, based on the count of public filings.

What declared insider buy and sell totals are available for ADURO BIOTECH, INC.?

Across the available history, declared buys total 0 and disposals 0.

InsiderTradesSIGMA

InsidersTradesSigma

← Companies ★ Sign in to follow

ADURO BIOTECH, INC. Stock: price and directors' dealings · United States · SEC (Form 4)

Source idSEC:aduro-biotech-inc-931876·SEC (Form 4)Mcap US$2.2B

SEC (Form 4)

Follow the ADURO BIOTECH, INC. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 11 January 2016 (Levée d'options). Among the most active insiders: ISAACS STEPHEN T. The full history is accessible without an account.

Insider Decl.

n/a

Thresholds

n/a

Buy Volume

n/a

13 ops.

Sell Volume

Analyst consensus: bullish or bearish?

Analysts rate ADURO BIOTECH, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.

Sigma AI Analysis

Fundamental view, insider signal, bull and bear case, synthesis.

AI analysis generation is paused.

Last declaration on 11 January 2016

Declarations22 total

◇

SCHAFER GREGORY W

Chief Operating OfficerExecutives8 Jan 2016

ADURO BIOTECH, INC. Stock: price and directors' dealings · United States · SEC (Form 4)

Analyst consensus: bullish or bearish?

关于 ADURO BIOTECH, INC.

Related companies and executives

ADURO BIOTECH, INC. Stock: price and directors' dealings · United States · SEC (Form 4)

Analyst consensus: bullish or bearish?

关于 ADURO BIOTECH, INC.

Related companies and executives